IDEA presents outcome of market surveillance study on Limonene and Linalool hydroperoxides at ESCD

2018
20 Oct

On Friday 19 October, 2018, IDEA hosted an Industry Symposium session at the European Society of Contact Dermatitis (ESCD) Congress in Milan, Italy.

Dr Andreas Natsch (Givaudan), Chair of the IDEA Hydroperoxides Task Force, presented the outcome of the market surveillance study on Limonene and Linalool hydroperoxides. Dr Matthias Vey (IDEA Management Team) also made a presentation.

The IDEA Hydroperoxides Task Force with support of an external laboratory has performed a study aiming to quantify the amount of Limonene and Linalool hydroperoxides present in marketed consumer products.

In their presentations, Dr Natsch and Dr Vey outlined the general objectives and program elements of IDEA and presented the analytical approach and the results of the market study on Limonene and Linalool hydroperoxides.

Click the links below to read documents from the Workshop

Related Documents